Clal Biotechnology Industries Ltd. (TLV:CBI)
Israel · Delayed Price · Currency is ILS · Price in ILA 24.20
+0.50 (2.11%)
Oct 1, 2026, 2:24 PM IDT
TLV:CBI Market Cap
TLV:CBI has a market cap or net worth of 37.96 million as of October 2, 2026. Its market cap has decreased by -37.95% in one year.
Market Cap
37.96M
Enterprise Value
54.91M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
24.20
ChartMarket Cap Chart
Since July 23, 2007, TLV:CBI's market cap has decreased from 797.05M to 37.96M, a decrease of -95.24%. That is a compound annual growth rate of -14.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 37.96M | -20.39% |
| Dec 31, 2025 | 47.68M | -12.89% |
| Dec 31, 2024 | 54.74M | -12.09% |
| Dec 31, 2023 | 62.27M | -36.78% |
| Dec 29, 2022 | 98.50M | -46.87% |
| Dec 30, 2021 | 185.39M | -41.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 212.60M |
| Matricelf | 77.42M |
| BioLineRx | 36.69M |
| Purple Biotech | 32.42M |
| BioLight Life Sciences | 26.45M |
| XTL Biopharmaceuticals | 23.84M |
| Evogene | 20.24M |
| Can-Fite BioPharma | 14.12M |